https://prosomnus.com/prosomnus-sleep-technologies-announces-donation-to-international-rescue-committee-to-benefit-families-displaced-from-ukraine/ 2024-08-29T10:00:01+00:00 https://prosomnus.com/prosomnus-leader-in-patient-preferred-sleep-apnea-therapy-to-be-listed-on-nasdaq-through-business-combination-with-lakeshore-acquisition-i-corp/ 2024-08-29T10:12:32+00:00 https://prosomnus.com/prosomnus-named-to-inc-5000-list-of-fastest-growing-companies-for-fourth-consecutive-year/ 2024-08-30T03:02:11+00:00 https://prosomnus.com/podcast-prosomnus-lakeshore-i-laaa-discuss-sleep-apnea-the-med-device-sector-and-spacs/ 2024-08-30T03:34:31+00:00 https://prosomnus.com/prosomnus-sleep-technologies-to-participate-at-the-oppenheimer-private-company-showcase/ 2024-08-30T03:36:00+00:00 https://prosomnus.com/lakeshore-acquisition-corp-i-shareholders-approve-business-combination-with-prosomnus/ 2024-08-30T04:21:34+00:00 https://prosomnus.com/prosomnus-enrolls-first-participant-in-study-evaluating-safety-and-efficacy-of-prosomnus-evo-in-treating-severe-obstructive-sleep-apnea/ 2024-08-30T04:27:07+00:00 https://prosomnus.com/prosomnus-appoints-brian-dow-as-chief-financial-officer/ 2024-08-30T04:47:56+00:00 https://prosomnus.com/prosomnus-to-present-at-two-upcoming-investor-conferences-in-march-2023/ 2024-08-30T04:49:05+00:00 https://prosomnus.com/prosomnus-announces-acceptance-of-abstract-at-european-respiratory-society-and-european-sleep-research-societys-sleep-and-breathing-2023-conference/ 2024-08-30T04:50:04+00:00 https://prosomnus.com/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023/ 2024-08-30T04:51:03+00:00 https://prosomnus.com/prosomnus-receives-patent-allowance-covering-automated-manufacturing-process-for-companys-novel-precision-sleep-apnea-medical-devices/ 2024-08-30T04:52:29+00:00 https://prosomnus.com/prosomnus-receives-additional-u-s-utility-patent-covering-iterative-titration-technology-for-companys-novel-precision-sleep-apnea-medical-devices/ 2024-08-30T04:58:24+00:00 https://prosomnus.com/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences/ 2024-08-30T05:03:30+00:00 https://prosomnus.com/data-presented-at-the-2023-american-academy-of-dental-sleep-medicine-and-the-american-thoracic-society-meetings-further-validate-prosomnus-precision-oral-appliance-therapy-for-the-treatment/ 2024-08-30T05:07:06+00:00 https://prosomnus.com/data-presented-at-the-2023-sleep-annual-meeting-strengthens-evidence-for-prosomnus-precision-oral-appliance-therapy-for-the-treatment-of-obstructive-sleep-apnea/ 2024-08-30T05:08:49+00:00 https://prosomnus.com/71-of-self-identified-snorers-have-never-consulted-a-healthcare-professional/ 2024-08-30T05:10:11+00:00 https://prosomnus.com/test/ 2024-08-30T06:21:09+00:00 https://prosomnus.com/updated-clinical-trial-data-indicates-precision-oral-appliance-therapy-with-prosomnus-devices-is-non-inferior-to-cpap-therapy-for-the-treatment-of-moderate-to-severe-obstructive-sleep-apnea/ 2024-08-30T06:25:49+00:00 https://prosomnus.com/prosomnus-precision-obstructive-sleep-apnea-devices-to-be-featured-in-scientific-abstracts-and-podium-presentations-at-upcoming-medical-conferences/ 2024-08-30T06:27:08+00:00 https://prosomnus.com/prosomnus-raises-10-million-to-fuel-growth-and-optimize-operations/ 2024-08-30T06:28:21+00:00 https://prosomnus.com/prosomnus-announces-participation-in-the-2023-roth-capital-healthcare-opportunities-conference/ 2024-08-30T06:29:18+00:00 https://prosomnus.com/prosomnus-announces-third-quarter-2023-investor-call-and-business-update/ 2024-08-30T06:30:22+00:00 https://prosomnus.com/data-published-by-cureus-journal-of-medical-science-shows-successful-treatment-of-obstructive-sleep-apnea-with-prosomnus-precision-oral-appliance-devices/ 2024-08-30T06:32:38+00:00 https://prosomnus.com/test-2/ 2024-08-30T06:40:25+00:00 https://prosomnus.com/prosomnus-poised-to-support-obstructive-sleep-apnea-patients-following-discontinuation-of-philips-respironics-osa-devices/ 2024-08-30T06:41:48+00:00 https://prosomnus.com/prosomnus-severe-indication-510k-submission-accepted-for-review-by-the-fda/ 2024-08-30T06:42:47+00:00 https://prosomnus.com/prosomnus-announces-fourth-quarter-and-fiscal-year-2023-investor-and-business-update-call-and-participation-at-the-36th-annual-roth-conference-in-march-2024/ 2024-08-30T06:43:51+00:00 https://prosomnus.com/prosomnus-reports-successful-pilot-study-validation-of-next-generation-remote-patient-monitoring-device-for-obstructive-sleep-apnea/ 2024-08-30T06:44:54+00:00 https://prosomnus.com/prosomnus-reschedules-fourth-quarter-and-fiscal-year-2023-investor-and-business-update-call/ 2024-08-30T06:45:54+00:00 https://prosomnus.com/prosomnus-sleep-technologies-takes-strategic-action-to-position-company-for-long-term-success/ 2024-08-30T06:48:23+00:00 https://prosomnus.com/four-independent-scientific-abstracts-at-the-american-academy-of-dental-sleep-medicine-annual-meeting-feature-prosomnus-intraoral-medical-devices/ 2024-08-30T06:49:24+00:00 https://prosomnus.com/prosomnus-contributes-two-scientific-abstracts-accepted-for-presentation-at-the-2024-american-academy-of-dental-sleep-medicine-annual-meeting/ 2024-08-30T06:50:36+00:00 https://prosomnus.com/prosomnus-announces-strong-first-quarter-2024-revenue-growth/ 2024-08-30T06:51:47+00:00 https://prosomnus.com/prosomnus-to-design-head-to-head-clinical-trial-vs-hypoglossal-nerve-stimulation/ 2024-08-30T08:59:29+00:00 https://prosomnus.com/study-to-be-presented-at-european-respiratory-society-and-european-sleep-research-societys-sleep-and-breathing-2023-conference-demonstrates-efficacy-of-prosomnus-precision-oral-appliances/ 2024-08-30T09:00:45+00:00 https://prosomnus.com/prosomnus-announces-publication-of-four-accepted-abstracts-in-the-journal-of-dental-sleep-medicine-in-advance-of-annual-meeting/ 2024-08-30T09:01:07+00:00 https://prosomnus.com/prosomnus-provides-business-update-and-preliminary-2022-revenue-guidance/ 2024-08-30T09:02:31+00:00 https://prosomnus.com/prosomnus-announces-acceptance-of-abstract-for-oral-presentation-at-prestigious-american-thoracic-society-2023-international-conference/ 2024-08-30T09:02:36+00:00 https://prosomnus.com/prosomnus-announces-completion-of-enrollment-in-antwerp-university-hospitals-first-line-obstructive-sleep-apnea-treatment-study-flosat/ 2024-08-30T09:03:37+00:00 https://prosomnus.com/prosomnus-announces-medicare-reimbursement-for-prosomnus-evo-ph-sleep-apnea-and-snoring-device/ 2024-08-30T09:04:06+00:00 https://prosomnus.com/study-published-in-military-medicine-reports-88-success-treating-obstructive-sleep-apnea-patients-with-precision-oral-appliance-therapy/ 2024-08-30T09:05:11+00:00 https://prosomnus.com/prosomnus-debuts-as-publicly-traded-company-focused-on-disrupting-obstructive-sleep-apnea-treatment-market-with-patient-preferred-precision-oral-appliance-therapy-devices/ 2024-08-30T09:05:20+00:00 https://prosomnus.com/prosomnus-reports-third-quarter-financial-results-and-provides-corporate-update/ 2024-08-30T09:05:30+00:00 https://prosomnus.com/prosomnus-announces-fda-510k-clearance-for-prosomnus-evo-ph-sleep-and-snore-device/ 2024-08-30T09:06:16+00:00 https://prosomnus.com/prosomnus-announces-availability-of-insurance-reimbursement-for-oral-appliance-therapy-devices-in-germany/ 2024-08-30T09:06:41+00:00 https://prosomnus.com/prosomnus-sleep-technologies-announces-signing-of-definitive-agreements-for-30-million-of-convertible-notes-2/ 2024-08-30T09:06:47+00:00 https://prosomnus.com/prosomnus-sleep-technologies-announces-signing-of-definitive-agreements-for-30-million-of-convertible-notes/ 2024-08-30T09:06:58+00:00 https://prosomnus.com/prosomnus-to-host-first-annual-prosleep-users-conference/ 2024-08-30T09:07:55+00:00 https://prosomnus.com/prosomnus-to-open-new-global-headquarters-and-manufacturing-center-of-excellence-increasing-manufacturing-capacity-and-efficiency/ 2024-08-30T09:08:01+00:00 https://prosomnus.com/prosomnus-to-present-data-at-sleep-2022-the-annual-meeting-of-the-american-academy-of-sleep-medicine-and-the-sleep-research-society/ 2024-08-30T09:08:09+00:00 https://prosomnus.com/prosomnus-sleep-technologies-to-present-three-posters-at-sleep-2022-the-annual-meeting-of-the-american-academy-of-sleep-medicine-and-the-sleep-research-society/ 2024-08-30T09:08:17+00:00 https://prosomnus.com/prosomnus-presents-data-validating-proprietary-fda-cleared-oral-appliance-therapy-devices-at-2022-american-academy-of-dental-sleep-medicine-annual-meeting/ 2024-08-30T09:08:23+00:00 https://prosomnus.com/prosomnus-sleep-technologies-to-present-three-posters-at-2022-american-academy-of-dental-sleep-medicine-annual-meeting/ 2024-08-30T09:09:17+00:00 https://prosomnus.com/journal-of-clinical-sleep-medicine-publication-shows-efficacy-of-prosomnus-precision-oral-appliance-therapy-devices-in-treating-obstructive-sleep-apnea/ 2024-08-30T09:09:26+00:00 https://prosomnus.com/prosomnus-sleep-technologies-to-present-data-showcasing-efficacy-of-novel-oral-appliance-therapy-devices-for-treatment-of-obstructive-sleep-apnea-at-world-sleep-congress-2022/ 2024-08-30T09:10:15+00:00 https://prosomnus.com/prosomnus-sleep-technologies-to-present-data-on-its-oral-appliance-therapy-devices-for-the-treatment-of-obstructive-sleep-apnea-at-world-sleep-congress-2022/ 2024-08-30T09:10:20+00:00 https://prosomnus.com/prosomnus-reports-fourth-quarter-and-fiscal-year-2022-financial-results/ 2024-08-30T09:19:13+00:00 https://prosomnus.com/prosomnus-reports-first-quarter-2023-financial-results/ 2024-08-30T09:28:09+00:00 https://prosomnus.com/prosomnus-reports-record-second-quarter-2023-top-line-financial-results/ 2024-08-30T09:32:13+00:00 https://prosomnus.com/prosomnus-the-leading-non-cpap-obstructive-sleep-apnea-therapy-reports-record-third-quarter-2023-financial-results/ 2024-08-30T09:35:01+00:00 https://prosomnus.com/prosomnus-reports-record-fourth-quarter-and-fiscal-year-2023-financial-results/ 2024-08-30T09:38:32+00:00 https://prosomnus.com/prosomnus-sleep-technologies-announces-record-revenues-as-it-emerges-from-reorganization/ 2024-10-10T05:57:17+00:00 https://prosomnus.com/prosomnus-listed-on-the-2025-inc-5000-list-of-americas-fastest-growing-private-companies/ 2025-08-26T14:12:17+00:00 https://prosomnus.com/prosomnus-announces-significant-progress-strategic-programs/ 2025-08-26T14:12:22+00:00 https://prosomnus.com/prosumnus-introduces-evo-guided-for-the-treatment-of-obstructive-sleep-apnea/ 2025-08-26T14:12:26+00:00 https://prosomnus.com/prosomnus-secures-38-million-strategic-investment-from-catalio-capital-management-to-scale-smart-sleep-medicine/ 2026-02-18T17:31:52+00:00 https://prosomnus.com/prosomnus-receives-fda-class-ii-clearance-for-rpmo2-osa-device/ 2026-04-16T02:25:35+00:00